SERUM-CHOLESTEROL CONCENTRATION AND DEATH FROM SUICIDE IN MEN - PARISPROSPECTIVE-STUDY-I

Citation
M. Zureik et al., SERUM-CHOLESTEROL CONCENTRATION AND DEATH FROM SUICIDE IN MEN - PARISPROSPECTIVE-STUDY-I, BMJ. British medical journal, 313(7058), 1996, pp. 649-651
Citations number
11
Categorie Soggetti
Medicine, General & Internal
ISSN journal
09598138
Volume
313
Issue
7058
Year of publication
1996
Pages
649 - 651
Database
ISI
SICI code
0959-8138(1996)313:7058<649:SCADFS>2.0.ZU;2-C
Abstract
Objective-To investigate whether low serum cholesterol concentration o r changing serum cholesterol concentration is associated with risk of suicide in men. Design-Cohort study with annual repeat measurements of serum cholesterol concentration (for up to four years). Setting-Paris , France. Subjects-6393 working men, aged 43-52 in 1967-72, who had at least three measurements of serum cholesterol concentration. Main out come measures-Individual change over time in serum cholesterol concent ration (estimated using within person linear regression method); death hom suicide during average of 17 years) follow up after last examinat ion. Results-32 men committed suicide during follow up. After adjustme nt for age and other factors, relative risk of suicide for men with lo w average serum cholesterol concentration (<4.78 mmol/l) compared with those with average serum cholesterol concentration of 4.78-6.21 mmol/ l was 3.16 (95% confidence interval 1.38 to 7.22, P = 0.007). Men whos e serum cholesterol concentration decreased by more than 0.13 mmol/l a year had multivariate adjusted relative risk of 2.17 (0.97 to 4.84, P = 0.056) compared with those whose cholesterol remained stable (chang e of less than or equal to 0.13 mmol/l a year). Conclusion-Both low se rum cholesterol concentration and declining cholesterol concentration were associated with increased risk of death from suicide in men. Alth ough there is some evidence in favour of a concomitant rather than a c ausal effect for interpreting these associations, long term surveillan ce of subjects included in trials of lipid lowering treatments seems w arranted.